Aqumeldi
- Prescription status not stated
- Heart, blood pressure and circulation
- Active substance
- Enalapril maleate
- Made by
- Proveca Pharma Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of heart failure.
From the official label · 2026-09-30 · European Medicines Agency
How it works
From the US prescribing label for the same active substance (Enalapril Maleate). It describes the substance, not this exact product.
Enalapril, after hydrolysis to enalaprilat, inhibits angiotensin-converting enzyme (ACE) in human subjects and animals.
ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II.
A high-fat meal reduced the C max of enalapril and enalaprilat by 46% and 36%, respectively.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2019-03-29
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Proveca Pharma Limited |
|---|---|
| Active substance | Enalapril maleate |
| Used in | Heart, blood pressure and circulation |
| Classification | C09AA02 · Heart, blood pressure and circulation |
| Authorised on | 2023-11-15 |
| Last updated by the regulator | 2025-10-21 |
| EMA product number | EMEA/H/C/005731 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).